Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation

Abstract

BackgroundAcute myeloid leukemia (AML) is the second most common form of leukemia in children. Aberrant DNA methylation patterns are a characteristic feature in various tumors, including AML. Metallothionein III (MT3) is a tumor suppresser reported to show promoter hypermethylated in various cancers. However, the expression and molecular function of MT3 in pediatric AML is unclear.MethodsEleven human leukemia cell lines and 41 pediatric AML samples and 20 NBM/ITP (Norma bone marrow/Idiopathic thrombocytopenic purpura) control samples were analyzed. Transcription levels of MT3 were evaluated by semi-quantitative and real-time PCR. MT3 methylation status was determined by methylation specific PCR (MSP) and bisulfite genomic sequencing (BSG). The molecular mechanism of MT3 was investigated by apoptosis assays and PCR array analysis.ResultsThe MT3 promoter was hypermethylated in leukemia cell lines. More CpG’s methylated of MT3 was observed 39.0% pediatric AML samples compared to 10.0% NBM controls. Transcription of MT3 was also significantly decreased in AML samples compared to NBM/ITP controls (P < 0.001); patients with methylated MT3 exhibited lower levels of MT3 expression compared to those with unmethylated MT3 (P = 0.049). After transfection with MT3 lentivirus, proliferation was significantly inhibited in AML cells in a dose-dependent manner (P < 0.05). Annexin V assay showed that apoptosis was significantly upregulated MT3-overexpressing AML cells compared to controls. Real-time PCR array analysis revealed 34 dysregulated genes that may be implicated in MT3 overexpression and apoptosis in AML, including FOXO1.ConclusionMT3 may be a putative tumor suppressor gene in pediatric AML. Epigenetic inactivation of MT3 via promoter hypermethylation was observed in both AML cell lines and pediatric AML samples. Overexpression of MT3 may inhibit proliferation and induce apoptosis in AML cells. FOXO1 was dysregulated in MT3-overexpressing cells, offering an insight into the mechanism of MT3-induced apoptosis. However, further research is required to determine the underlying molecular details.

In VitroProtective Effects ofLycium barbarumBerries Cultivated in Umbria (Italy) on Human Hepatocellular Carcinoma Cells

“…Prostaglandin H synthase 1 (PTGS1) is implicated in colorectal carcinogenesis [47] and it is considered a good target for cancer therapy [48]. Metallothionein 3 (MT3) is considered a putative tumor suppressor gene [49]. Decreased expression of MT3 has been found in gastric cancer, esophageal adenocarcinoma, and squamous cell cancer [50, 51].…”

Copper nanoparticle-induced ovarian injury, follicular atresia, apoptosis, and gene expression alterations in female rats

“…Evidence has shown that metallothioneins (MTs) play vital roles in protecting against DNA damage and apoptosis, and these proteins are often divided into four classes (MT1-4). 49 MT3 has been identified as a growth inhibitor factor that could inhibit neuritis formation and survival in neurons. 50 Overexpression of MT3 may inhibit proliferation and induce apoptosis.…”

Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses

“…MT3 is a tumor suppressor gene, and its expression is significantly reduced in AML samples. The overexpression of MT3 can inhibit cell proliferation and promote tumor cell apoptosis in pediatric acute myeloid leukemia (Tao et al, 2014). SH3GL2, as a suppressor for tumors, and has reduced expression in glioma tissues promoting migration and infiltration of glioma cells by enhancing STAT3/MMP2 signaling (Zhu et al, 2017).…”